Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 4, 1998, Pages 351-356

  Weeratna, Risini ^a   Millan, Cynthia L Brazolot ^a   Krieg, Arthur M ^b,c   Davis, Heather L ^a,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DINUCLEOTIDE; DNA VACCINE; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID; PLASMID DNA;

ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); VERTEBRATA;

EID: 0031684269     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.351     Document Type: Article

References (26)

1. BALLAS, Z.K., RASMUSSEN, W.L., and KRIEG, A.M. (1996). Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1845.
2. BIRD, A.P. (1987). CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3, 342.
3. BOGGS, R.T., MCGRAW, K., CONDON, T., FLOURNOY, S., VILLIET, P., BENNETT, C.F., and MONIA, B.P. (1997). Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev. 7, 461-471.
4. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. CHACE, J.H., HOOKER, N.A., MILDENSTEIN, K.L., KRIEG, A.M., and COWDERY, J.S. (1997). Bacterial DNA-induced NK cell IFN-g production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84, 185-193.
6. CHU, R.S., TARGONI, O.S., KRIEG, A.M., LEHMANN, P.V., and HARDING, C.V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186, 1623-1631.
7. COWDERY, J.S., CHACE, J.H., YI, A.-K., and KRIEG, A.M. (1996). Bacterial DNA induces NK cells to produce interferon-g in vivo and increases the toxicity of lipopolysaccharide. J. Immunol. 156, 4570-4575.
8. DAVIS, H.L., MICHEL, M.-L., and WHALEN, R.G. (1993a). DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum. Mol. Genet. 2, 1847-1851.
9. DAVIS, H.L., WEERATNA, R., WALDSCHMIDT, T.J., SCHORR, J., and KRIEG, A.M. (1998). CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870-876.
10. DAVIS, H.L., WHALEN, R.G., and DEMENEIX, B.A. (1993b). Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151-159.
11. GRIBAUDO, G., RAVAGLIA, S., CALIENDO, A., CAVALLO, R., GARIGLIO, M., MARTINOTTI, M.G., and LANDOLFO, S. (1993). Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197, 303-311.
12. HALPERN, M.D., KURLANDER, R.J., and PISETSKY, D.S. (1996). Bacterial DNA induces murine interferon-g production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell. Immunol. 167, 72-78.
13. HARMS, J.S., and SPLITTER, G.A. (1995). Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6, 1291-1297.
14. HUGHES, J.A., AWRUTSKAYA, A.V., and JULIANO, R.L. (1994). Influence of base composition cellular uptake of 10-mer phospho-rothioate oligonucleotides in Chinese hamster ovary (CHRC5) cells. Antisense Res. Dev. 4, 211-215.
15. KIMURA, Y., SONEHARA, K., KURAMOTO, E., MAKINO, T., YAMAMOTO, S., YAMAMOTO, T., KATAOKA, T., and TOKUNAGA, T. (1994). Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. 116, 991-994.
16. KLINMAN, D.M., YAMSHCHIKOV, G., and ISHIGATSUBO, Y. (1997). Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158, 3635-3639.
17. KLINMAN, D.M., YI, A., BEAUCAGE, S.L., CONOVER, J., and KRIEG, A.M. (1996). CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFN-γ. Proc. Natl. Acad. Sci. USA 93, 2879-2883.
18. KRIEG, A.M., YI, A.-K., SCHORR, J., and DAVIS, H.L. (1997). The role of CpG dinucleotides in DNA vaccines. Trends Immunol. 6, 23-26.
19. KRIEG, A.M. (1996). An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J. Lab. Clin. Med. 128, 128-133.
20. KRIEG, A.M., MATSON, S., HERRERA, C., and FISHER, E. (1996). Oligodeoxynucleotide modifications determine the magnitude of immune stimulation by CpG motifs. Antisense Res. Dev. 6, 133-139.
21. KRIEG, A.M., YI, A.-K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
22. LIPFORD, G.B., SPARWASSER, T., BAUER, M., ZIMMERMANN, S., KOCH, E.-S., HEEG, K., and WAGNER, H. (1997). Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27, 3420-3426.
23. WEINER, G.J., LIU, H.-M., WOOLDRIDGE, J.E., DAHLE, C.E., and KRIEG, A.M. (1997). Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA 94, 10833-10837.
24. YAMAMOTO, S., YAMAMOTO, T., SHIMADA, S., KURAMOTO, E., YANO, O., KATAOKA, T., and TOKUNAGA, T. (1992). DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36, 983-997.
25. ZHAO, Q., MATSON, S., HERRERA, C.J., FISHER, E., YU, H., and KRIEG, A.M. (1993). Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53-66.
26. ZHAO, Q., TEMSAMANI, J., IADAROLA, P.L., JIANG, Z., and AGRAWAL, S. (1996). Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51, 173-182.